Background
==========

Cigarette smoking causes coronary endothelial dysfunction and is a major risk factor for ischemic heart disease and acute ST-elevation myocardial infarction (STEMI) \[[@B1]\]. Prior studies have found that the mortality rate of smokers after AMI may paradoxically be lower than in non-smokers \[[@B2]\]. Epidemiological studies have failed to find a dose-dependent relationship between cardiovascular risk and the number of cigarettes smoked \[[@B3]\]. We used CMR to analyse myocardial infarct size and salvage % in patients following primary percutaneous coronary intervention (PPCI), categorising smokers as never-, ex- and current smokers.

Methods
=======

In a prospective single-centre study sixty one patients underwent CMR on a 1.5T Philips Achieva (Best, Netherlands) during the first week following PPCI for acute STEMI. The ischemic area-at-risk was assessed with T2-weighted imaging and myocardial necrosis with late gadolinium enhancement. Myocardial salvage quantification was performed using certified analysis software (cmr42, Circle Cardiovascular Imaging, Alberta, Canada) (Fig [1](#F1){ref-type="fig"}). Statistical analysis was carried out using SPSS 19.0 (IBM, Armonk, NY).
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Results
=======

Infarct size was normally distributed (by Normal plots and Shapiro Wilk testing). Univariate regression analysis showed smoking status was the only factor significantly associated with infarct size (R2=0.085, p=0.02) (Fig [2](#F2){ref-type="fig"}). Univariate regression analysis also showed pain-to-balloon time to be the only factor significantly associated with salvage (R2=0.085, p=0.02).

![Association of smoking on infarct size. 0= Never Smoked 1= Ex-smoker 2= Current Smoker](1532-429X-15-S1-O107-2){#F2}

Conclusions
===========

Smoking is associated with smaller infarcts but is not an independent predictor of myocardial salvage. This study further highlights the debate surrounding the \"smokers\' paradox\". Ischemic pre-conditioning, as well as favourable baseline clinical and angiographic characteristics, may be responsible for the more benign prognosis of current smokers \[[@B4]\]. Adaptations in the coronary microcirculation and the subsequent response to ischemia-reperfusion injury may underlie the pathophysiological differences seen in smokers \[[@B5]\].
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